http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106148529-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate | 2016-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106148529-B |
| titleOfInvention | LncRNA marker related to gastric cancer, special detection primer, detection method, kit and application thereof |
| abstract | The invention discloses an LncRNA marker related to gastric cancer, a special detection primer, a detection method, a kit and application thereof. The LncRNA marker is named as LINP1, the nucleotide sequence of the LncRNA marker is shown as SEQ NO.1 in a sequence table, the nucleotide sequence of an upstream primer (LINP1-F) of the LncRNA marker is shown as SEQ NO.2 in the sequence table, and the nucleotide sequence of a downstream primer (LINP1-R) of the LncRNA marker is shown as SEQ NO.3 in the sequence table, wherein the primer is used for detecting LINP 1. The LINP1 provided by the invention is a long-chain non-coding RNA particularly related to gastric cancer, the expression level of LINP1 can be detected from tissues with high specificity, the detection operation is simple and convenient, the quantification is accurate, the clinical judgment of the postoperative recurrence rate and the prognosis effect of a gastric cancer patient is facilitated, and the LINP1 can be used for screening gastric cancer treatment drugs and providing help for the development of new drugs. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106811525-A |
| priorityDate | 2016-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 168.